December 21, 2021
FDA Conditionally Approves First Oral Tablet to Treat Chemotherapy-Induced Diarrhea in Dogs
For immediate release: December 21, 2021 Today the US Food and Drug Administration conditionally approved Canalevia-CA1 (Crofelemer sustained-release tablets) for the treatment of chemotherapy-induced diarrhea in dogs. This is the first treatment approved for this condition. “Diarrhea is a common side effect of chemotherapy in dogs that can be severe enough to have to stop cancer treatment. Chemotherapy drugs often …